Clinical Trial Update: Study Comparing Effect On Carotid Atherosclerosis Following Conversion From Tacrolimus To Sirolimus Post-Transplant In Kidney Transplant Patients [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating conversion from tacrolimus to sirolimus on carotid atherosclerosis in kidney transplant patients was terminated, with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• End-stage Renal Disease

Drugs mentioned

• Sirolimus (Sirolimus)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Pfizer | Conditions: Atherosclerosis, Kidney Failure | Phase 3 | Status: TERMINATED | Results posted: 2012-05-24